Rifaximin for gut bacteria after stem cell transplant in leukemia
Treatments studied
Part of Cancer, Digestive system, Infections clinical trials.
This trial tests whether the antibiotic rifaximin can help protect the healthy bacteria in your gut after a stem cell transplant for acute leukemia. It may reduce infections and other complications during your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acute leukemia and are getting a stem cell transplant from a donor.
- You are generally active and able to care for yourself (ECOG 0, 1, or 2).
- Your liver function is adequate.
- You are not allergic to rifaximin or similar antibiotics.
- You do not have inflammatory bowel disease (like Crohn's or colitis) now or in the past.
- You have not had major bowel surgery or a colostomy.
- You are not taking Verapamil, ketoconazole, or itraconazole.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking the antibiotic rifaximin just before and after a living-donor liver transplant can help prevent early problems with the new liver. It may be an option for adults having this surgery at the study hospital.
This trial tests if adding the drug Rifaximin can help prevent diarrhea caused by radiation therapy for pelvic cancers. It may be an option for people starting radiation or chemoradiation for non-metastatic pelvic cancer.
This trial tests whether an oral antibiotic called rifaximin can improve symptoms during a microscopic colitis flare. It aims to see if it is safe and effective for people whose colitis was confirmed by colon biopsy.
This trial tests whether giving a transplant of healthy gut bacteria (fecal microbiota transplant) before a stem cell transplant can improve outcomes for people with certain blood cancers or bone marrow disorders.
This study tests whether a medicine called rifaximin, taken along with oral rehydration solution, helps children aged 6 to 11 recover faster from acute (short-lasting) diarrhea that is likely caused by a bacterial infection. The study compares rifaximin plus oral rehydration versus oral rehydration alone.
This trial tests whether the antibiotic rifaximin (taken by mouth) can improve heart function in people with a type of heart failure where the heart pumps well but is still weak (HFpEF). Rifaximin might help by changing the bacteria in your gut.
Hear when a new Acute Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.